acetylcysteine and Movement Disorders

acetylcysteine has been researched along with Movement Disorders in 3 studies

Research

Studies (3)

Timeframe	Studies, this research(%)	All Research%
pre-1990	0 (0.00)	18.7374
1990's	0 (0.00)	18.2507
2000's	2 (66.67)	29.6817
2010's	1 (33.33)	24.3611
2020's	0 (0.00)	2.80

Authors

Authors	Studies
Dinelle, K; Doudet, DJ; Flores, J; Jing, Y; Mackey, S	1
Aoyama, K; Matsumura, N; Nakaki, T; Watabe, M	1
Anderson-Hunt, M; Berk, M; Bush, AI; Conus, P; Copolov, D; Cuenod, M; Dean, O; Do, KQ; Jeavons, S; Judd, F; Katz, F; Katz, P; Little, J; Lu, K; Ording-Jespersen, S; Schapkaitz, I	1

Trials

1 trial(s) available for acetylcysteine and Movement Disorders

Article	Year
N-acetyl cysteine as a glutathione precursor for schizophrenia--a double-blind, randomized, placebo-controlled trial. Biological psychiatry, 2008, Sep-01, Volume: 64, Issue:5 Topics: Acetylcysteine; Adult; Analysis of Variance; Double-Blind Method; Female; Free Radical Scavengers; Humans; Male; Middle Aged; Movement Disorders; Outcome Assessment, Health Care; Psychiatric Status Rating Scales; Schizophrenia	2008

Article

Year

N-acetyl cysteine as a glutathione precursor for schizophrenia--a double-blind, randomized, placebo-controlled trial.

Biological psychiatry, 2008, Sep-01, Volume: 64, Issue:5

Topics: Acetylcysteine; Adult; Analysis of Variance; Double-Blind Method; Female; Free Radical Scavengers; Humans; Male; Middle Aged; Movement Disorders; Outcome Assessment, Health Care; Psychiatric Status Rating Scales; Schizophrenia

2008

Other Studies

2 other study(ies) available for acetylcysteine and Movement Disorders

Article	Year
Direct intranigral administration of an ubiquitin proteasome system inhibitor in rat: behavior, positron emission tomography, immunohistochemistry. Experimental neurology, 2013, Volume: 247 Topics: Acetylcysteine; Analysis of Variance; Animals; Carbon Isotopes; Cell Count; Corpus Striatum; Cysteine Proteinase Inhibitors; Disease Models, Animal; Dose-Response Relationship, Drug; Functional Laterality; Hindlimb; Locomotion; Movement Disorders; Positron-Emission Tomography; Rats; Rats, Sprague-Dawley; Substantia Nigra; Tetrabenazine; Time Factors; Tyrosine 3-Monooxygenase	2013
Oxidative stress on EAAC1 is involved in MPTP-induced glutathione depletion and motor dysfunction. The European journal of neuroscience, 2008, Volume: 27, Issue:1 Topics: 1-Methyl-4-phenylpyridinium; Acetylcysteine; Animals; Aspartic Acid; Behavior, Animal; Cysteine; Disease Models, Animal; Drug Interactions; Excitatory Amino Acid Transporter 1; Free Radical Scavengers; Glutathione; Humans; Hydrogen Peroxide; Hydroxamic Acids; In Vitro Techniques; Indazoles; Male; Mice; Mice, Inbred C57BL; Movement Disorders; MPTP Poisoning; Neuroprotective Agents; Oxidative Stress; Substantia Nigra	2008

Article

Year

Direct intranigral administration of an ubiquitin proteasome system inhibitor in rat: behavior, positron emission tomography, immunohistochemistry.

Experimental neurology, 2013, Volume: 247

Topics: Acetylcysteine; Analysis of Variance; Animals; Carbon Isotopes; Cell Count; Corpus Striatum; Cysteine Proteinase Inhibitors; Disease Models, Animal; Dose-Response Relationship, Drug; Functional Laterality; Hindlimb; Locomotion; Movement Disorders; Positron-Emission Tomography; Rats; Rats, Sprague-Dawley; Substantia Nigra; Tetrabenazine; Time Factors; Tyrosine 3-Monooxygenase

2013

Oxidative stress on EAAC1 is involved in MPTP-induced glutathione depletion and motor dysfunction.

The European journal of neuroscience, 2008, Volume: 27, Issue:1

Topics: 1-Methyl-4-phenylpyridinium; Acetylcysteine; Animals; Aspartic Acid; Behavior, Animal; Cysteine; Disease Models, Animal; Drug Interactions; Excitatory Amino Acid Transporter 1; Free Radical Scavengers; Glutathione; Humans; Hydrogen Peroxide; Hydroxamic Acids; In Vitro Techniques; Indazoles; Male; Mice; Mice, Inbred C57BL; Movement Disorders; MPTP Poisoning; Neuroprotective Agents; Oxidative Stress; Substantia Nigra

2008